CorMedix's DefenCath Ignites Stellar Q3 Performance, Elevating Full-Year Revenue Projections

Beyond Vaccines: Moderna Co-Founder Warns of Widespread Attacks on Science

A Landmark Clash: India's Supreme Court Navigates Life-Saving SMA Drugs, Patents, and Public Access

Beyond COVID: mRNA Vaccines Unleash a New Weapon Against Cancer's Toughest Foes

A New Dawn for Early Breast Cancer: Enhertu's Groundbreaking Impact Revealed at ESMO 2025

A New Dawn for Breast Cancer Treatment: Roche's Gedatolisib and Giredestrant Combination Shows Promise

Taysha Gene Therapies Stock Takes a Dive: Unpacking the Impact of Their Latest Public Offering

Biotech's Vanguard: Novo Nordisk, Omeros, and GSK Charting New Territories in Medical Innovation

A Looming Crisis: Funding Cuts Threaten Revolutionary Cancer Immunotherapy Breakthroughs

Omeros Stock Skyrockets: Novo Nordisk Seals Massive $2.1 Billion Rare Disease Drug Deal

Bavarian Nordic's Future Intensifies: A Higher Bid Ignites Take-Private Battle

North Carolina's Biotech Boom: Powering the Future of Medicine Through Advanced Manufacturing

Takeda and Nabla Bio Forge $1 Billion Alliance to Revolutionize Antibody Design with AI

FDA Pumps the Brakes: Denali Therapeutics' Hunter Syndrome Drug Faces Extended Review

BioCryst Pharmaceuticals Strikes Strategic $700 Million Deal, Propelling Astria's HAE Pipeline and Strengthening Its Own Focus

A New Dawn for ITP Patients: Telitacicept Shows Remarkable Promise in Autoimmune Disorder

Clinical Setback: Tvardi Therapeutics' Lung Disease Candidate Falls Short in Crucial Trial

Cullinan Therapeutics' Breakthrough Cancer Drug Shows Remarkable Efficacy Against Brain Metastases in Lung Cancer Patients

The Production Predicament: How Manufacturing Woes Threaten Novo Nordisk's Blockbuster Drugs

Monopar Therapeutics: A Biotech Powerhouse Poised for Explosive Growth?

Beyond Cancer: Nkarta Pioneers a New Era for Autoimmune Diseases with Groundbreaking NK Cell Therapy

UK's Controversial Drug Price Hike: Pharma Giants Hit the Brakes on Investment

A Ray of Hope: Mainz Biomed's Pancreatic Cancer Test Delivers Unprecedented Early Detection Results

Unlocking Tomorrow's Cures: Bristol Myers Squibb's Daring Dive into Next-Gen Autoimmune Cell Therapies

US BioSecure Act Ignites Indian Pharma: A New Era for CDMOs

A New Dawn Against Breast Cancer: Telomir-1 Shows Remarkable Promise

Boston-Cambridge: The Unrivaled Epicenter of Global Biotech Innovation

Biohaven's Breakthrough Bid: Navigating FDA Flexibility for Spinocerebellar Ataxia's Future

Biomea Fusion Shares Plummet as Major Public Offering Rocks Investor Confidence Despite Positive Diabetes Data

Valneva's 2025 Outlook Takes a Hit as Key Vaccine Marketing Rights Shift in Brazil

Midday Market Movers: Biotech Rockets, Tech Soars, and a Coffee Giant Stumbles

A New Horizon for Breast Cancer: Enhertu Shows Groundbreaking Survival Benefit in HER2-low Metastatic Patients

The Great Pharmaceutical Reversal: Onshoring's Costly Gamble with Drug Affordability

Europe's Bold New Pharma Gambit: A High-Stakes Bet on Access Over Profit?

Pharma's Big Win: How a Judge's Ruling Ignited Big Pharma Stocks

A Deluge of Innovation: Six IPOs Storm the Market, From Data Security to Biotech Breakthroughs

Phyllis Gardner, Stanford's Unwavering Voice of Truth Against Theranos, Passes Away

Crucial Medicare Drug Price Loophole Fix Stalled: A Setback for Patient Savings

Taysha Gene Therapies' TSHA-102 Receives FDA Breakthrough Status: A New Hope for Rett Syndrome